Bio-Rad Laboratories (BIO) Share-based Compensation (2009 - 2025)

Bio-Rad Laboratories (BIO) has 17 years of Share-based Compensation data on file, last reported at $400000.0 in Q4 2025.

• On a quarterly basis, Share-based Compensation rose 100.94% year-over-year to $400000.0 in Q4 2025; TTM through Dec 2025 was -$51.1 million, a 315.04% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 11.76% from the prior year.
• Share-based Compensation for Q4 2025 stood at $400000.0, up from -$24.6 million in the prior quarter.
• Over the last five years, Share-based Compensation for BIO reached as high as $44.8 million in Q3 2023 and fell as low as -$42.5 million in Q4 2024.
• Historically, Share-based Compensation has averaged -$2142.9 across 5 years, with a median of $262000.0 in 2022.
• On a YoY basis, Share-based Compensation climbed as much as 438.69% in 2023 and fell as far as 24454.84% in 2023.
• Year by year, Share-based Compensation stood at -$13.7 million in 2021, then jumped by 100.9% to $124000.0 in 2022, then plunged by 24454.84% to -$30.2 million in 2023, then slumped by 40.73% to -$42.5 million in 2024, then soared by 100.94% to $400000.0 in 2025.
• Per Business Quant data, the three most recent Share-based Compensation figures were $400000.0 in Q4 2025, -$24.6 million in Q3 2025, and -$42.5 million in Q4 2024.